Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 2,230 | 4,414 | 2,051 | 2,458 | 2,273 |
| Operating Income | -2,230 | -4,414 | -2,051 | -2,458 | -2,273 |
| Other Income | -17 | -158 | -82 | -164 | 414 |
| Pre-tax Income | -2,247 | -4,572 | -2,133 | -2,622 | -1,859 |
| Net Income Continuous | -2,247 | -4,572 | -2,133 | -2,622 | -1,859 |
| Net Income | $-2,247 | $-4,572 | $-2,133 | $-2,622 | $-1,859 |
| EPS Basic Total Ops | -0.06 | -0.14 | -0.06 | -0.09 | -0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.14 | -0.06 | -0.09 | -0.06 |
| EPS Diluted Total Ops | -0.06 | -0.14 | -0.06 | -0.09 | -0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.14 | -0.06 | -0.09 | -0.06 |
| EBITDA(a) | $-2,220 | $-4,404 | $-2,041 | $-2,448 | $-2,263 |